Carbamazepine drug reaction involving high fevers during the COVID-19 era

Carbamazepine drug reaction involving high fevers during the COVID-19 era

Carbamazepine has demonstrated anticonvulsant properties and is used for a variety of indications in psychiatry and neurology. Total daily doses typically range from 200 to 1200 mg/d, generally divided into 2 doses. Carbamazepine has a broad side-effect profile but is not typically thought to produc...

Full description

Bibliographic Details
Main Authors: Reuben Heyman-Kantor, MD, Matthew Perez, MD, Arti Phatak, PharmD, BCPS, Danielle L. Anderson, MD
Format: Article
Language:English
Published: American Association of Psychiatric Pharmacists 2021-09-01
Series:Mental Health Clinician
Subjects:
carbamazepine
adverse drug reaction
covid-19
coronavirus
bipolar disorder
case report
Online Access:https://theijpt.org/doi/pdf/10.9740/mhc.2021.09.287

Internet

https://theijpt.org/doi/pdf/10.9740/mhc.2021.09.287

Similar Items